Sarah M. Groves

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay, C. Allison Stewart, Elizabeth M. Park et al. · Cancer Cell · 2021 · 932 citations · Full text

Medicine, Cancer Biology, Molecular Biology +10

Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizers

David J. Wooten, Sarah M. Groves, Darren R. Tyson et al. · PLoS Computational Biology · 2019 · 119 citations · Full text

Life Sciences, Oncology, Systems Biology +17

ASCL1 represses a SOX9 ⁺ neural crest stem-like state in small cell lung cancer

Rachelle R. Olsen, Abbie S. Ireland, David W. Kastner et al. · Genes & Development · 2021 · 77 citations · Full text

Medicine, Genetics, Oncology +16

Archetype tasks link intratumoral heterogeneity to plasticity and cancer hallmarks in small cell lung cancer

Sarah M. Groves, Geena V. Ildefonso, Caitlin O. McAtee et al. · Cell Systems · 2022 · 59 citations · Full text

Medicine, Cancer Biology, Oncology +17

Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC

Portia Thomas, Sarah M. Groves, Yun-Kai Zhang et al. · Journal of Thoracic Oncology · 2021 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17